GRM Overseas, a small-cap fast-moving consumer goods (FMCG) company, announced a 2% increase in its share price following the launch of its new product, '10X Basmati Rice Suitable for Diabetics.' This product aims to address the growing demand for healthier food options due to rising diabetes cases and health consciousness among consumers. Currently, the stock is trading 11% below its 52-week high, reflecting strong market interest. The diabetic food market is projected to grow at a CAGR of 6-8% globally, with India expected to see a growth rate of approximately 10%. GRM has transformed from a small rice processing business into a key player in the consumer staples sector, exporting to 42 countries and ranking among the top five rice exporters in India. The company operates three processing facilities in Haryana and Gujarat, with a total annual capacity of 440,800 metric tonnes. Analysts suggest that the stock is in a consolidation phase, with immediate resistance at ₹175. A breakout above this level could lead to positive momentum.